These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22529752)

  • 1. Prioritizing CD4 count monitoring in response to ART in resource-constrained settings: a retrospective application of prediction-based classification.
    Azzoni L; Foulkes AS; Liu Y; Li X; Johnson M; Smith C; Kamarulzaman AB; Montaner J; Mounzer K; Saag M; Cahn P; Cesar C; Krolewiecki A; Sanne I; Montaner LJ
    PLoS Med; 2012; 9(4):e1001207. PubMed ID: 22529752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
    Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
    PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M
    HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of ART in resource-limited countries.
    Loubiere S; Meiners C; Sloan C; Freedberg KA; Yazdanpanah Y
    Curr Opin HIV AIDS; 2010 May; 5(3):225-31. PubMed ID: 20539078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute lymphocyte count as a marker for CD4 T-lymphocyte count: criterion for initiating antiretroviral therapy in HIV infected Nigerians.
    Erhabor O; Uko EK; Adias T
    Niger J Med; 2006; 15(1):56-9. PubMed ID: 16649453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
    Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
    Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
    PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.
    Kimmel AD; Goldie SJ; Walensky RP; Losina E; Weinstein MC; Paltiel AD; Zhang H; Freedberg KA;
    Antivir Ther; 2005; 10(1):41-52. PubMed ID: 15751762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POC CD4 Testing Improves Linkage to HIV Care and Timeliness of ART Initiation in a Public Health Approach: A Systematic Review and Meta-Analysis.
    Vojnov L; Markby J; Boeke C; Harris L; Ford N; Peter T
    PLoS One; 2016; 11(5):e0155256. PubMed ID: 27175484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings.
    Sukapirom K; Onlamoon N; Thepthai C; Polsrila K; Tassaneetrithep B; Pattanapanyasat K
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):141-7. PubMed ID: 21709568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.
    Diomandé FV; Bissagnéné E; Nkengasong JN; Maurice C; Monga B; Laga M; Nolan ML
    AIDS; 2003 Jul; 17 Suppl 3():S87-93. PubMed ID: 14565614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T lymphocytes enumeration by an easy-to-use single platform image cytometer for HIV monitoring in resource-constrained settings.
    Li X; Ymeti A; Lunter B; Breukers C; Tibbe AG; Terstappen LW; Greve J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):397-407. PubMed ID: 17311352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.
    Leisegang R; Cleary S; Hislop M; Davidse A; Regensberg L; Little F; Maartens G
    PLoS Med; 2009 Dec; 6(12):e1000189. PubMed ID: 19956658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
    Gezie LD
    BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.
    Suthar AB; Lawn SD; del Amo J; Getahun H; Dye C; Sculier D; Sterling TR; Chaisson RE; Williams BG; Harries AD; Granich RM
    PLoS Med; 2012; 9(7):e1001270. PubMed ID: 22911011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.
    Buclin T; Telenti A; Perera R; Csajka C; Furrer H; Aronson JK; Glasziou PP
    PLoS One; 2011 Apr; 6(4):e18578. PubMed ID: 21494630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.